117 results
Page 3 of 6
8-K
fcfb2c9gcxa3o1p
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
SD
EX-1.01
5e26uc ldq6t
31 May 22
Conflict minerals disclosure
4:07pm
424B5
qy0jj4jg09l9
4 May 22
Prospectus supplement for primary offering
8:40am
8-K
67ytbv2d
31 Mar 22
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
4:19pm
8-K
rfwuw62nijqp833o cq5
21 Mar 22
Departure of Directors or Certain Officers
4:52pm
8-K
pkh1 n4nb5pa
15 Feb 22
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
9:26am
8-K
EX-99.1
gmksxll5p b70
15 Nov 21
Pulse Biosciences Reports Third Quarter 2021 Financial Results
12:00am
8-K
EX-99.1
8wg6d8a
9 Aug 21
Pulse Biosciences Reports Second Quarter 2021 Financial Results
4:32pm
8-K
EX-10.1
ey3 wwd757l0m
1 Jul 21
Pulse Biosciences Announces $50 Million Private Placement
8:33am
8-K
EX-99.1
96gu52a0i7s
1 Jul 21
Pulse Biosciences Announces $50 Million Private Placement
8:33am
8-K
EX-10.1
klu3ksus2vmi mu6nuj
10 Jun 21
Other Events
4:41pm
8-K
EX-99.1
ix5tusgyjce19 8o0b
9 Jun 21
Pulse Biosciences Announces Health Canada Approval for CellFX® System
8:22am